A Phase Ia Clinical Study of QLF31907 Injection in Patients With Advanced Malignant Tumors

Clinical trial NCT05150405 · UNKNOWN

Trial details

NCT number: NCT05150405
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Lymphoma, Non-Hodgkin

Start date: 2021-10-19
Primary completion: 2024-03-31
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.